ritanserin has been researched along with beta-endorphin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Den Boer, JA; Westenberg, HG | 1 |
| Facchinetti, F; Genazzani, AR; Marini, S; Martignoni, E; Nappi, G; Petraglia, F; Sandrini, G | 1 |
1 trial(s) available for ritanserin and beta-endorphin
| Article | Year |
|---|---|
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
Topics: Adult; beta-Endorphin; Blood Platelets; Double-Blind Method; Fear; Female; Fluvoxamine; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Melatonin; Mental Disorders; Methoxyhydroxyphenylglycol; Norepinephrine; Oximes; Panic; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Ritanserin; Serotonin | 1990 |
1 other study(ies) available for ritanserin and beta-endorphin
| Article | Year |
|---|---|
Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan-induced beta-EP, beta-LPH and cortisol secretion.
Topics: 5-Hydroxytryptophan; Adolescent; beta-Endorphin; beta-Lipotropin; Endorphins; Humans; Hydrocortisone; Male; Piperidines; Ritanserin; Secretory Rate; Serotonin; Time Factors | 1987 |